Delivery Order SPE2DR25D1201-SPE2DR26FAJPX
- Not listed
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Qualipita 60 mg tablets (30-count units) with a ceiling value of $11,073.97 and an ultimate completion date of October 22, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement designated SPE2DX and...
- The Defense Logistics Agency awarded a delivery order valued at $2,289.25 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Qualipita 60 mg tablets (30-count units). This firm fixed-price contract, with an ultimate completion date of August 26, 2025, represents a competitive, non-set-aside award for pharmaceutical delivery to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $16,035.05 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Qualipita 60 mg tablets (30-count packages). This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. The pharmaceutical will be supplied from the contractor's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Qualipita 60 mg tablets in a 30-count configuration. This firm fixed-price delivery order, valued at $21,802.28, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, which carries a $999,999,999.00 ceiling and extends through December 2026. The award was made without a set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $54,878.67 to AmerisourceBergen Drug Corp for the supply of Qualipita 60 mg tablets (30-count packages) on October 30, 2025, with completion expected by October 31, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,372.53 to AmerisourceBergen Drug Corp for the supply of Qualipita 60 mg tablets (30-count units) on November 5, 2025, with an ultimate completion date of November 6, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Qualipita 60 mg tablets (30-count) with a ceiling value of $6,073.01. This competitively awarded, firm fixed-price delivery order is not associated with any set-aside designation and requires completion by July 11, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,875.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Qualipita 60 mg tablets (30-count units) on May 23, 2025, with an ultimate completion date of May 27, 2025. This non-set-aside contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of Qualipta 60 mg tablets in a quantity of 30 units. This is a firm fixed-price delivery order with a ceiling value of $7,570.62 and an ultimate completion date of October 20, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's largest...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Qualipita 60 mg tablets (30-count units) with a ceiling value of $1,534.32. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to the...
- SPE2DR25D1201Indefinite Delivery Contract
- SPE2DR25D1201-SPE2DR26FAJPXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Qualipita 60 mg tablets (30-count units) with a ceiling value of $9,959.89. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is set for ultimate completion by October 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse medical supply needs, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. All reviewed contract awards with this vendor have been competitively awarded with firm fixed pricing, ranging from minimal-value transactions to substantial orders, indicating consistent performance in meeting federal procurement requirements within the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 10/27/25 |